Medical Care
Global Placental Stem Cell Therapy for Neurological Disorders Market Research Report 2025
- May 12, 25
- ID: 237418
- Pages: 85
- Figures: 82
- Views: 15
The global market for Placental Stem Cell Therapy for Neurological Disorders was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Placental stem cell therapy for neurological disorders involves the use of stem cells derived from the placenta to treat conditions affecting the nervous system. These cells have the potential to differentiate into various specialized cell types, promoting neural regeneration and repair. This therapeutic approach aims to address conditions like Parkinson"s disease, Alzheimer"s, and spinal cord injuries, offering a promising avenue for regenerative medicine in neurology by harnessing the regenerative capabilities of placental-derived stem cells.
The industry trend for placental stem cell therapy in neurological disorders is marked by ongoing research and clinical trials to explore its efficacy and safety. As advancements in stem cell technology and understanding of neurobiology progress, there"s a growing interest in developing targeted and personalized therapies. Regulatory frameworks are evolving to accommodate these innovative treatments. The trend also involves collaborations between academia, biotech companies, and healthcare institutions to accelerate the translation of research findings into practical and accessible therapeutic solutions, reflecting a positive outlook for the integration of placental stem cell therapy into neurological care.
This report aims to provide a comprehensive presentation of the global market for Placental Stem Cell Therapy for Neurological Disorders, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Placental Stem Cell Therapy for Neurological Disorders.
The Placental Stem Cell Therapy for Neurological Disorders market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Placental Stem Cell Therapy for Neurological Disorders market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Placental Stem Cell Therapy for Neurological Disorders companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mesoblast
Pleurite Therapeutic
Athersys
Cordlife India
Life Cell
Cryo-Cell
CBR Systems
ReNeuron Group
Cynata
Celularity
Americord Registry
ReeLabs
Mesoblast
Segment by Type
Allogeneic Placental Stem Cell Therapy
Autologous Placental Stem Cell Therapy
Segment by Application
Hospitals and Specialist Clinics
Clinical Research Institute
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Placental Stem Cell Therapy for Neurological Disorders company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Placental stem cell therapy for neurological disorders involves the use of stem cells derived from the placenta to treat conditions affecting the nervous system. These cells have the potential to differentiate into various specialized cell types, promoting neural regeneration and repair. This therapeutic approach aims to address conditions like Parkinson"s disease, Alzheimer"s, and spinal cord injuries, offering a promising avenue for regenerative medicine in neurology by harnessing the regenerative capabilities of placental-derived stem cells.
The industry trend for placental stem cell therapy in neurological disorders is marked by ongoing research and clinical trials to explore its efficacy and safety. As advancements in stem cell technology and understanding of neurobiology progress, there"s a growing interest in developing targeted and personalized therapies. Regulatory frameworks are evolving to accommodate these innovative treatments. The trend also involves collaborations between academia, biotech companies, and healthcare institutions to accelerate the translation of research findings into practical and accessible therapeutic solutions, reflecting a positive outlook for the integration of placental stem cell therapy into neurological care.
This report aims to provide a comprehensive presentation of the global market for Placental Stem Cell Therapy for Neurological Disorders, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Placental Stem Cell Therapy for Neurological Disorders.
The Placental Stem Cell Therapy for Neurological Disorders market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Placental Stem Cell Therapy for Neurological Disorders market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Placental Stem Cell Therapy for Neurological Disorders companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mesoblast
Pleurite Therapeutic
Athersys
Cordlife India
Life Cell
Cryo-Cell
CBR Systems
ReNeuron Group
Cynata
Celularity
Americord Registry
ReeLabs
Mesoblast
Segment by Type
Allogeneic Placental Stem Cell Therapy
Autologous Placental Stem Cell Therapy
Segment by Application
Hospitals and Specialist Clinics
Clinical Research Institute
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Placental Stem Cell Therapy for Neurological Disorders company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Allogeneic Placental Stem Cell Therapy
1.2.3 Autologous Placental Stem Cell Therapy
1.3 Market by Application
1.3.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Specialist Clinics
1.3.3 Clinical Research Institute
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Perspective (2020-2031)
2.2 Global Placental Stem Cell Therapy for Neurological Disorders Growth Trends by Region
2.2.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Placental Stem Cell Therapy for Neurological Disorders Historic Market Size by Region (2020-2025)
2.2.3 Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Region (2026-2031)
2.3 Placental Stem Cell Therapy for Neurological Disorders Market Dynamics
2.3.1 Placental Stem Cell Therapy for Neurological Disorders Industry Trends
2.3.2 Placental Stem Cell Therapy for Neurological Disorders Market Drivers
2.3.3 Placental Stem Cell Therapy for Neurological Disorders Market Challenges
2.3.4 Placental Stem Cell Therapy for Neurological Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Revenue
3.1.1 Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Revenue (2020-2025)
3.1.2 Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Players (2020-2025)
3.2 Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Placental Stem Cell Therapy for Neurological Disorders Revenue
3.4 Global Placental Stem Cell Therapy for Neurological Disorders Market Concentration Ratio
3.4.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Placental Stem Cell Therapy for Neurological Disorders Revenue in 2024
3.5 Global Key Players of Placental Stem Cell Therapy for Neurological Disorders Head office and Area Served
3.6 Global Key Players of Placental Stem Cell Therapy for Neurological Disorders, Product and Application
3.7 Global Key Players of Placental Stem Cell Therapy for Neurological Disorders, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Placental Stem Cell Therapy for Neurological Disorders Breakdown Data by Type
4.1 Global Placental Stem Cell Therapy for Neurological Disorders Historic Market Size by Type (2020-2025)
4.2 Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Type (2026-2031)
5 Placental Stem Cell Therapy for Neurological Disorders Breakdown Data by Application
5.1 Global Placental Stem Cell Therapy for Neurological Disorders Historic Market Size by Application (2020-2025)
5.2 Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Placental Stem Cell Therapy for Neurological Disorders Market Size (2020-2031)
6.2 North America Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025)
6.4 North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size (2020-2031)
7.2 Europe Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025)
7.4 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size (2020-2031)
8.2 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2020-2025)
8.4 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size (2020-2031)
9.2 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025)
9.4 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size (2020-2031)
10.2 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025)
10.4 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mesoblast
11.1.1 Mesoblast Company Details
11.1.2 Mesoblast Business Overview
11.1.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Introduction
11.1.4 Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.1.5 Mesoblast Recent Development
11.2 Pleurite Therapeutic
11.2.1 Pleurite Therapeutic Company Details
11.2.2 Pleurite Therapeutic Business Overview
11.2.3 Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Introduction
11.2.4 Pleurite Therapeutic Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.2.5 Pleurite Therapeutic Recent Development
11.3 Athersys
11.3.1 Athersys Company Details
11.3.2 Athersys Business Overview
11.3.3 Athersys Placental Stem Cell Therapy for Neurological Disorders Introduction
11.3.4 Athersys Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.3.5 Athersys Recent Development
11.4 Cordlife India
11.4.1 Cordlife India Company Details
11.4.2 Cordlife India Business Overview
11.4.3 Cordlife India Placental Stem Cell Therapy for Neurological Disorders Introduction
11.4.4 Cordlife India Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.4.5 Cordlife India Recent Development
11.5 Life Cell
11.5.1 Life Cell Company Details
11.5.2 Life Cell Business Overview
11.5.3 Life Cell Placental Stem Cell Therapy for Neurological Disorders Introduction
11.5.4 Life Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.5.5 Life Cell Recent Development
11.6 Cryo-Cell
11.6.1 Cryo-Cell Company Details
11.6.2 Cryo-Cell Business Overview
11.6.3 Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Introduction
11.6.4 Cryo-Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.6.5 Cryo-Cell Recent Development
11.7 CBR Systems
11.7.1 CBR Systems Company Details
11.7.2 CBR Systems Business Overview
11.7.3 CBR Systems Placental Stem Cell Therapy for Neurological Disorders Introduction
11.7.4 CBR Systems Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.7.5 CBR Systems Recent Development
11.8 ReNeuron Group
11.8.1 ReNeuron Group Company Details
11.8.2 ReNeuron Group Business Overview
11.8.3 ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Introduction
11.8.4 ReNeuron Group Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.8.5 ReNeuron Group Recent Development
11.9 Cynata
11.9.1 Cynata Company Details
11.9.2 Cynata Business Overview
11.9.3 Cynata Placental Stem Cell Therapy for Neurological Disorders Introduction
11.9.4 Cynata Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.9.5 Cynata Recent Development
11.10 Celularity
11.10.1 Celularity Company Details
11.10.2 Celularity Business Overview
11.10.3 Celularity Placental Stem Cell Therapy for Neurological Disorders Introduction
11.10.4 Celularity Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.10.5 Celularity Recent Development
11.11 Americord Registry
11.11.1 Americord Registry Company Details
11.11.2 Americord Registry Business Overview
11.11.3 Americord Registry Placental Stem Cell Therapy for Neurological Disorders Introduction
11.11.4 Americord Registry Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.11.5 Americord Registry Recent Development
11.12 ReeLabs
11.12.1 ReeLabs Company Details
11.12.2 ReeLabs Business Overview
11.12.3 ReeLabs Placental Stem Cell Therapy for Neurological Disorders Introduction
11.12.4 ReeLabs Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.12.5 ReeLabs Recent Development
11.13 Mesoblast
11.13.1 Mesoblast Company Details
11.13.2 Mesoblast Business Overview
11.13.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Introduction
11.13.4 Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.13.5 Mesoblast Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Allogeneic Placental Stem Cell Therapy
1.2.3 Autologous Placental Stem Cell Therapy
1.3 Market by Application
1.3.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Specialist Clinics
1.3.3 Clinical Research Institute
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Perspective (2020-2031)
2.2 Global Placental Stem Cell Therapy for Neurological Disorders Growth Trends by Region
2.2.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Placental Stem Cell Therapy for Neurological Disorders Historic Market Size by Region (2020-2025)
2.2.3 Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Region (2026-2031)
2.3 Placental Stem Cell Therapy for Neurological Disorders Market Dynamics
2.3.1 Placental Stem Cell Therapy for Neurological Disorders Industry Trends
2.3.2 Placental Stem Cell Therapy for Neurological Disorders Market Drivers
2.3.3 Placental Stem Cell Therapy for Neurological Disorders Market Challenges
2.3.4 Placental Stem Cell Therapy for Neurological Disorders Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Revenue
3.1.1 Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Revenue (2020-2025)
3.1.2 Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Players (2020-2025)
3.2 Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Placental Stem Cell Therapy for Neurological Disorders Revenue
3.4 Global Placental Stem Cell Therapy for Neurological Disorders Market Concentration Ratio
3.4.1 Global Placental Stem Cell Therapy for Neurological Disorders Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Placental Stem Cell Therapy for Neurological Disorders Revenue in 2024
3.5 Global Key Players of Placental Stem Cell Therapy for Neurological Disorders Head office and Area Served
3.6 Global Key Players of Placental Stem Cell Therapy for Neurological Disorders, Product and Application
3.7 Global Key Players of Placental Stem Cell Therapy for Neurological Disorders, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Placental Stem Cell Therapy for Neurological Disorders Breakdown Data by Type
4.1 Global Placental Stem Cell Therapy for Neurological Disorders Historic Market Size by Type (2020-2025)
4.2 Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Type (2026-2031)
5 Placental Stem Cell Therapy for Neurological Disorders Breakdown Data by Application
5.1 Global Placental Stem Cell Therapy for Neurological Disorders Historic Market Size by Application (2020-2025)
5.2 Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Placental Stem Cell Therapy for Neurological Disorders Market Size (2020-2031)
6.2 North America Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025)
6.4 North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size (2020-2031)
7.2 Europe Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025)
7.4 Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size (2020-2031)
8.2 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2020-2025)
8.4 Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size (2020-2031)
9.2 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025)
9.4 Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size (2020-2031)
10.2 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025)
10.4 Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mesoblast
11.1.1 Mesoblast Company Details
11.1.2 Mesoblast Business Overview
11.1.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Introduction
11.1.4 Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.1.5 Mesoblast Recent Development
11.2 Pleurite Therapeutic
11.2.1 Pleurite Therapeutic Company Details
11.2.2 Pleurite Therapeutic Business Overview
11.2.3 Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Introduction
11.2.4 Pleurite Therapeutic Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.2.5 Pleurite Therapeutic Recent Development
11.3 Athersys
11.3.1 Athersys Company Details
11.3.2 Athersys Business Overview
11.3.3 Athersys Placental Stem Cell Therapy for Neurological Disorders Introduction
11.3.4 Athersys Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.3.5 Athersys Recent Development
11.4 Cordlife India
11.4.1 Cordlife India Company Details
11.4.2 Cordlife India Business Overview
11.4.3 Cordlife India Placental Stem Cell Therapy for Neurological Disorders Introduction
11.4.4 Cordlife India Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.4.5 Cordlife India Recent Development
11.5 Life Cell
11.5.1 Life Cell Company Details
11.5.2 Life Cell Business Overview
11.5.3 Life Cell Placental Stem Cell Therapy for Neurological Disorders Introduction
11.5.4 Life Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.5.5 Life Cell Recent Development
11.6 Cryo-Cell
11.6.1 Cryo-Cell Company Details
11.6.2 Cryo-Cell Business Overview
11.6.3 Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Introduction
11.6.4 Cryo-Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.6.5 Cryo-Cell Recent Development
11.7 CBR Systems
11.7.1 CBR Systems Company Details
11.7.2 CBR Systems Business Overview
11.7.3 CBR Systems Placental Stem Cell Therapy for Neurological Disorders Introduction
11.7.4 CBR Systems Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.7.5 CBR Systems Recent Development
11.8 ReNeuron Group
11.8.1 ReNeuron Group Company Details
11.8.2 ReNeuron Group Business Overview
11.8.3 ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Introduction
11.8.4 ReNeuron Group Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.8.5 ReNeuron Group Recent Development
11.9 Cynata
11.9.1 Cynata Company Details
11.9.2 Cynata Business Overview
11.9.3 Cynata Placental Stem Cell Therapy for Neurological Disorders Introduction
11.9.4 Cynata Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.9.5 Cynata Recent Development
11.10 Celularity
11.10.1 Celularity Company Details
11.10.2 Celularity Business Overview
11.10.3 Celularity Placental Stem Cell Therapy for Neurological Disorders Introduction
11.10.4 Celularity Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.10.5 Celularity Recent Development
11.11 Americord Registry
11.11.1 Americord Registry Company Details
11.11.2 Americord Registry Business Overview
11.11.3 Americord Registry Placental Stem Cell Therapy for Neurological Disorders Introduction
11.11.4 Americord Registry Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.11.5 Americord Registry Recent Development
11.12 ReeLabs
11.12.1 ReeLabs Company Details
11.12.2 ReeLabs Business Overview
11.12.3 ReeLabs Placental Stem Cell Therapy for Neurological Disorders Introduction
11.12.4 ReeLabs Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.12.5 ReeLabs Recent Development
11.13 Mesoblast
11.13.1 Mesoblast Company Details
11.13.2 Mesoblast Business Overview
11.13.3 Mesoblast Placental Stem Cell Therapy for Neurological Disorders Introduction
11.13.4 Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
11.13.5 Mesoblast Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Allogeneic Placental Stem Cell Therapy
Table 3. Key Players of Autologous Placental Stem Cell Therapy
Table 4. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Region (2020-2025)
Table 8. Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Region (2026-2031)
Table 10. Placental Stem Cell Therapy for Neurological Disorders Market Trends
Table 11. Placental Stem Cell Therapy for Neurological Disorders Market Drivers
Table 12. Placental Stem Cell Therapy for Neurological Disorders Market Challenges
Table 13. Placental Stem Cell Therapy for Neurological Disorders Market Restraints
Table 14. Global Placental Stem Cell Therapy for Neurological Disorders Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Players (2020-2025)
Table 16. Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Stem Cell Therapy for Neurological Disorders as of 2024)
Table 17. Ranking of Global Top Placental Stem Cell Therapy for Neurological Disorders Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Placental Stem Cell Therapy for Neurological Disorders Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Placental Stem Cell Therapy for Neurological Disorders, Headquarters and Area Served
Table 20. Global Key Players of Placental Stem Cell Therapy for Neurological Disorders, Product and Application
Table 21. Global Key Players of Placental Stem Cell Therapy for Neurological Disorders, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Type (2020-2025)
Table 25. Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Type (2026-2031)
Table 27. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Application (2020-2025)
Table 29. Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Application (2026-2031)
Table 31. North America Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031) & (US$ Million)
Table 46. Mesoblast Company Details
Table 47. Mesoblast Business Overview
Table 48. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product
Table 49. Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 50. Mesoblast Recent Development
Table 51. Pleurite Therapeutic Company Details
Table 52. Pleurite Therapeutic Business Overview
Table 53. Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Product
Table 54. Pleurite Therapeutic Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 55. Pleurite Therapeutic Recent Development
Table 56. Athersys Company Details
Table 57. Athersys Business Overview
Table 58. Athersys Placental Stem Cell Therapy for Neurological Disorders Product
Table 59. Athersys Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 60. Athersys Recent Development
Table 61. Cordlife India Company Details
Table 62. Cordlife India Business Overview
Table 63. Cordlife India Placental Stem Cell Therapy for Neurological Disorders Product
Table 64. Cordlife India Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 65. Cordlife India Recent Development
Table 66. Life Cell Company Details
Table 67. Life Cell Business Overview
Table 68. Life Cell Placental Stem Cell Therapy for Neurological Disorders Product
Table 69. Life Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 70. Life Cell Recent Development
Table 71. Cryo-Cell Company Details
Table 72. Cryo-Cell Business Overview
Table 73. Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Product
Table 74. Cryo-Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 75. Cryo-Cell Recent Development
Table 76. CBR Systems Company Details
Table 77. CBR Systems Business Overview
Table 78. CBR Systems Placental Stem Cell Therapy for Neurological Disorders Product
Table 79. CBR Systems Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 80. CBR Systems Recent Development
Table 81. ReNeuron Group Company Details
Table 82. ReNeuron Group Business Overview
Table 83. ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Product
Table 84. ReNeuron Group Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 85. ReNeuron Group Recent Development
Table 86. Cynata Company Details
Table 87. Cynata Business Overview
Table 88. Cynata Placental Stem Cell Therapy for Neurological Disorders Product
Table 89. Cynata Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 90. Cynata Recent Development
Table 91. Celularity Company Details
Table 92. Celularity Business Overview
Table 93. Celularity Placental Stem Cell Therapy for Neurological Disorders Product
Table 94. Celularity Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 95. Celularity Recent Development
Table 96. Americord Registry Company Details
Table 97. Americord Registry Business Overview
Table 98. Americord Registry Placental Stem Cell Therapy for Neurological Disorders Product
Table 99. Americord Registry Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 100. Americord Registry Recent Development
Table 101. ReeLabs Company Details
Table 102. ReeLabs Business Overview
Table 103. ReeLabs Placental Stem Cell Therapy for Neurological Disorders Product
Table 104. ReeLabs Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 105. ReeLabs Recent Development
Table 106. Mesoblast Company Details
Table 107. Mesoblast Business Overview
Table 108. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product
Table 109. Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 110. Mesoblast Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Placental Stem Cell Therapy for Neurological Disorders Picture
Figure 2. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Type: 2024 VS 2031
Figure 4. Allogeneic Placental Stem Cell Therapy Features
Figure 5. Autologous Placental Stem Cell Therapy Features
Figure 6. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Application: 2024 VS 2031
Figure 8. Hospitals and Specialist Clinics Case Studies
Figure 9. Clinical Research Institute Case Studies
Figure 10. Placental Stem Cell Therapy for Neurological Disorders Report Years Considered
Figure 11. Global Placental Stem Cell Therapy for Neurological Disorders Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Placental Stem Cell Therapy for Neurological Disorders Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Region: 2024 VS 2031
Figure 14. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Players in 2024
Figure 15. Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Stem Cell Therapy for Neurological Disorders as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Placental Stem Cell Therapy for Neurological Disorders Revenue in 2024
Figure 17. North America Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2020-2031)
Figure 19. United States Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2020-2031)
Figure 23. Germany Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Share by Region (2020-2031)
Figure 31. China Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2020-2031)
Figure 39. Mexico Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2020-2031)
Figure 43. Turkey Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Mesoblast Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 47. Pleurite Therapeutic Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 48. Athersys Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 49. Cordlife India Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 50. Life Cell Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 51. Cryo-Cell Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 52. CBR Systems Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 53. ReNeuron Group Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 54. Cynata Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 55. Celularity Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 56. Americord Registry Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 57. ReeLabs Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 58. Mesoblast Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Allogeneic Placental Stem Cell Therapy
Table 3. Key Players of Autologous Placental Stem Cell Therapy
Table 4. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Region (2020-2025)
Table 8. Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Region (2026-2031)
Table 10. Placental Stem Cell Therapy for Neurological Disorders Market Trends
Table 11. Placental Stem Cell Therapy for Neurological Disorders Market Drivers
Table 12. Placental Stem Cell Therapy for Neurological Disorders Market Challenges
Table 13. Placental Stem Cell Therapy for Neurological Disorders Market Restraints
Table 14. Global Placental Stem Cell Therapy for Neurological Disorders Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Players (2020-2025)
Table 16. Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Stem Cell Therapy for Neurological Disorders as of 2024)
Table 17. Ranking of Global Top Placental Stem Cell Therapy for Neurological Disorders Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Placental Stem Cell Therapy for Neurological Disorders Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Placental Stem Cell Therapy for Neurological Disorders, Headquarters and Area Served
Table 20. Global Key Players of Placental Stem Cell Therapy for Neurological Disorders, Product and Application
Table 21. Global Key Players of Placental Stem Cell Therapy for Neurological Disorders, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Type (2020-2025)
Table 25. Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Type (2026-2031)
Table 27. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Application (2020-2025)
Table 29. Global Placental Stem Cell Therapy for Neurological Disorders Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Placental Stem Cell Therapy for Neurological Disorders Revenue Market Share by Application (2026-2031)
Table 31. North America Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size by Country (2026-2031) & (US$ Million)
Table 46. Mesoblast Company Details
Table 47. Mesoblast Business Overview
Table 48. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product
Table 49. Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 50. Mesoblast Recent Development
Table 51. Pleurite Therapeutic Company Details
Table 52. Pleurite Therapeutic Business Overview
Table 53. Pleurite Therapeutic Placental Stem Cell Therapy for Neurological Disorders Product
Table 54. Pleurite Therapeutic Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 55. Pleurite Therapeutic Recent Development
Table 56. Athersys Company Details
Table 57. Athersys Business Overview
Table 58. Athersys Placental Stem Cell Therapy for Neurological Disorders Product
Table 59. Athersys Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 60. Athersys Recent Development
Table 61. Cordlife India Company Details
Table 62. Cordlife India Business Overview
Table 63. Cordlife India Placental Stem Cell Therapy for Neurological Disorders Product
Table 64. Cordlife India Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 65. Cordlife India Recent Development
Table 66. Life Cell Company Details
Table 67. Life Cell Business Overview
Table 68. Life Cell Placental Stem Cell Therapy for Neurological Disorders Product
Table 69. Life Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 70. Life Cell Recent Development
Table 71. Cryo-Cell Company Details
Table 72. Cryo-Cell Business Overview
Table 73. Cryo-Cell Placental Stem Cell Therapy for Neurological Disorders Product
Table 74. Cryo-Cell Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 75. Cryo-Cell Recent Development
Table 76. CBR Systems Company Details
Table 77. CBR Systems Business Overview
Table 78. CBR Systems Placental Stem Cell Therapy for Neurological Disorders Product
Table 79. CBR Systems Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 80. CBR Systems Recent Development
Table 81. ReNeuron Group Company Details
Table 82. ReNeuron Group Business Overview
Table 83. ReNeuron Group Placental Stem Cell Therapy for Neurological Disorders Product
Table 84. ReNeuron Group Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 85. ReNeuron Group Recent Development
Table 86. Cynata Company Details
Table 87. Cynata Business Overview
Table 88. Cynata Placental Stem Cell Therapy for Neurological Disorders Product
Table 89. Cynata Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 90. Cynata Recent Development
Table 91. Celularity Company Details
Table 92. Celularity Business Overview
Table 93. Celularity Placental Stem Cell Therapy for Neurological Disorders Product
Table 94. Celularity Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 95. Celularity Recent Development
Table 96. Americord Registry Company Details
Table 97. Americord Registry Business Overview
Table 98. Americord Registry Placental Stem Cell Therapy for Neurological Disorders Product
Table 99. Americord Registry Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 100. Americord Registry Recent Development
Table 101. ReeLabs Company Details
Table 102. ReeLabs Business Overview
Table 103. ReeLabs Placental Stem Cell Therapy for Neurological Disorders Product
Table 104. ReeLabs Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 105. ReeLabs Recent Development
Table 106. Mesoblast Company Details
Table 107. Mesoblast Business Overview
Table 108. Mesoblast Placental Stem Cell Therapy for Neurological Disorders Product
Table 109. Mesoblast Revenue in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025) & (US$ Million)
Table 110. Mesoblast Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Placental Stem Cell Therapy for Neurological Disorders Picture
Figure 2. Global Placental Stem Cell Therapy for Neurological Disorders Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Type: 2024 VS 2031
Figure 4. Allogeneic Placental Stem Cell Therapy Features
Figure 5. Autologous Placental Stem Cell Therapy Features
Figure 6. Global Placental Stem Cell Therapy for Neurological Disorders Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Application: 2024 VS 2031
Figure 8. Hospitals and Specialist Clinics Case Studies
Figure 9. Clinical Research Institute Case Studies
Figure 10. Placental Stem Cell Therapy for Neurological Disorders Report Years Considered
Figure 11. Global Placental Stem Cell Therapy for Neurological Disorders Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Placental Stem Cell Therapy for Neurological Disorders Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Region: 2024 VS 2031
Figure 14. Global Placental Stem Cell Therapy for Neurological Disorders Market Share by Players in 2024
Figure 15. Global Top Placental Stem Cell Therapy for Neurological Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Stem Cell Therapy for Neurological Disorders as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Placental Stem Cell Therapy for Neurological Disorders Revenue in 2024
Figure 17. North America Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2020-2031)
Figure 19. United States Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2020-2031)
Figure 23. Germany Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Placental Stem Cell Therapy for Neurological Disorders Market Share by Region (2020-2031)
Figure 31. China Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2020-2031)
Figure 39. Mexico Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Placental Stem Cell Therapy for Neurological Disorders Market Share by Country (2020-2031)
Figure 43. Turkey Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Placental Stem Cell Therapy for Neurological Disorders Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Mesoblast Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 47. Pleurite Therapeutic Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 48. Athersys Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 49. Cordlife India Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 50. Life Cell Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 51. Cryo-Cell Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 52. CBR Systems Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 53. ReNeuron Group Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 54. Cynata Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 55. Celularity Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 56. Americord Registry Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 57. ReeLabs Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 58. Mesoblast Revenue Growth Rate in Placental Stem Cell Therapy for Neurological Disorders Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232